SCHEMBL8396751

SCHEMBL8396751

Nc1ccc(Cl)cc1C(=O)CC(N)C(=O)[O-].[Na+]

nearest known ligand 0.50

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 2/20 0.47
RECQL P46063 1/20 0.44
FADS1 O60427 1/20 0.40
ERCC5 P28715 1/20 0.38
FEN1 P39748 1/20 0.38
KMT2A Q03164 2/20 0.37
KDM4E B2RXH2 2/20 0.37
GLA P06280 1/20 0.37
ALDH1A1 P00352 1/20 0.37
GCK P35557 2/20 0.36
KMO O15229 2/20 0.36
GFER P55789 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP3A4 P08684 1/20 0.36
ABL1 P00519 1/20 0.36
HIF1A Q16665 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30852448 0.85 KMO (0.51) NOS2RECQLFADS1KDM4EKMO
SCHEMBL8397341 0.85 KMO (0.51) NOS2RECQLFADS1KDM4EKMO
SCHEMBL30852441 0.85 KMO (0.51) NOS2RECQLFADS1KDM4EKMO
SCHEMBL7967428 0.85 KMO (0.51) NOS2RECQLFADS1KDM4EKMO
SCHEMBL8397345 0.85 KMO (0.51) NOS2RECQLFADS1KDM4EKMO
SCHEMBL8396747 0.84 KMO (0.50) NOS2RECQLFADS1KDM4EKMO
SCHEMBL8396761 0.84 KMO (0.50) NOS2RECQLFADS1KDM4EKMO
SCHEMBL2450666 0.74 ALDH1A1 (0.61) NOS2RECQLFADS1ERCC5FEN1
Av-101 SCHEMBL727370 0.73 KMO (0.51) KDM4EALDH1A1KMOCYP3A4ABL1
Av-101 SCHEMBL18742668 0.73 KMO (0.51) KDM4EALDH1A1KMOCYP3A4ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0663899-B1 SUBSTITUTED KYNURENINES, A PROCESS FOR THEIR PREPARATION, AND USE AS MEDICAMENTS UNIV MARYLAND (US) 1999-06-30 EP disclosed
EP-0919538-A1 Substituted kynurenines, a process for their preparation, and use as medicaments THE UNIVERSITY OF MARYLAND AT BALTIMORE (US) 1999-06-02 EP disclosed
US-5786508-A ENZYME INHIBITOR; COGNITION ACTIVATOR PHARMACIA & UPJOHN S.P.A. (IT) 1998-07-28 US disclosed
US-5708030-A COGNITION ACTIVATORS, PERINATAL BRAIN DISORDERS UNIVERSITY OF MARYLAND (US) 1998-01-13 US disclosed
US-5519055-A ENZYME INHIBITORS UNIVERSITY OF MARYLAND AT BALTIMORE (US) 1996-05-21 US disclosed
EP-0663899-A4 SUBSTITUTED KYNURENINES, A PROCESS FOR THEIR PREPARATION, AND USE AS MEDICAMENTS. UNIV MARYLAND (US) 1996-01-17 EP disclosed
EP-0663899-A1 SUBSTITUTED KYNURENINES, A PROCESS FOR THEIR PREPARATION, AND USE AS MEDICAMENTS THE UNIVERSITY OF MARYLAND AT BALTIMORE (US) 1995-07-26 EP disclosed
WO-1995004714-A1 SUBSTITUTED KYNURENINES, A PROCESS FOR THEIR PREPARATION, AND USE AS MEDICAMENTS UNIVERSITY OF MARYLAND AT BALTIMORE (US) 1995-02-16 WO disclosed